Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$2.16B |
| 2 |
Eli Lilly
LLY
|
+$1.9B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.09B |
| 4 |
Cigna
CI
|
+$883M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$1.49B |
| 2 |
Comcast
CMCSA
|
+$1.34B |
| 3 |
Stryker
SYK
|
+$1.31B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 5 |
Walt Disney
DIS
|
+$1.2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 16.48% |
| 3 | Financials | 12.48% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Communication Services | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
PagerDuty
PD
$915M
| $10.5M | ﹤0.01% |
608,168
+466,424
| +329% | +$9.9M |
|
|
B
1627
DELISTED
Barnes Group Inc.
B
| $10.5M | ﹤0.01% |
250,872
-1,064
| -0.4% | -$60K |
|
1628
LiveOne
LVO
$62.8M
| $10.4M | ﹤0.01% |
660,012
-340
| -0.1% | -$4.91K |
|
1629
Teva Pharmaceuticals
TEVA
$42.5B
| $10.4M | ﹤0.01% |
1,152,923
+459,239
| +66% | +$4.7M |
|
|
GSV
1630
DELISTED
Gold Standard Ventures Corp.
GSV
| $10.4M | ﹤0.01% |
20,814,591
| – | – |
|
|
SCS
1631
DELISTED
Steelcase
SCS
| $10.3M | ﹤0.01% |
1,048,003
+1,047,424
| +180,902% | +$17.3M |
|
1632
G-III Apparel Group
GIII
$1.44B
| $10.3M | ﹤0.01% |
1,333,386
-741,295
| -36% | -$16.9M |
|
1633
Viking Therapeutics
VKTX
$3.94B
| $10.2M | ﹤0.01% |
2,177,654
-8,714
| -0.4% | -$53.6K |
|
1634
Intellia Therapeutics
NTLA
$1.68B
| $10.2M | ﹤0.01% |
831,744
-2,183
| -0.3% | -$29.4K |
|
1635
iShares New York Muni Bond ETF
NYF
$1.41B
| $10M | ﹤0.01% |
177,684
-78,518
| -31% | -$4.48M |
|
1636
UFP Technologies
UFPT
$2.49B
| $10M | ﹤0.01% |
263,207
+7,096
| +3% | +$326K |
|
1637
MaxLinear
MXL
$6.26B
| $10M | ﹤0.01% |
858,080
+537,202
| +167% | +$9M |
|
|
QTS.PRB
1638
DELISTED
QTS Realty Trust, Inc. 6.50% Series B Cumulative Convertible Perpetual Preferred Stock
QTS.PRB
| $9.95M | ﹤0.01% |
77,000
| – | – |
|
1639
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$14B
| $9.92M | ﹤0.01% |
315,534
-146,075
| -32% | -$5.5M |
|
1640
Casella Waste Systems
CWST
$5.89B
| $9.87M | ﹤0.01% |
252,564
-19,294
| -7% | -$936K |
|
1641
First Northwest Bancorp
FNWB
$106M
| $9.83M | ﹤0.01% |
904,425
-31,012
| -3% | -$475K |
|
1642
Cincinnati Financial
CINF
$26.6B
| $9.82M | ﹤0.01% |
130,175
+11,516
| +10% | +$1.15M |
|
|
EFC
1643
Ellington Financial
EFC
$1.74B
| $9.79M | ﹤0.01% |
1,714,126
-153,959
| -8% | -$2.4M |
|
1644
Factset
FDS
$10.1B
| $9.78M | ﹤0.01% |
37,500
+5,482
| +17% | +$1.49M |
|
1645
Rapid7
RPD
$894M
| $9.76M | ﹤0.01% |
225,319
+173,749
| +337% | +$9.11M |
|
|
AEPPL
1646
DELISTED
American Electric Power Company, Inc. Corporate Unit
AEPPL
| $9.71M | ﹤0.01% |
202,400
+100,000
| +98% | +$5.39M |
|
1647
Halliburton
HAL
$28.2B
| $9.71M | ﹤0.01% |
1,416,865
-3,159,492
| -69% | -$55M |
|
|
CVET
1648
DELISTED
Covetrus, Inc. Common Stock
CVET
| $9.64M | ﹤0.01% |
1,184,087
+129,502
| +12% | +$1.48M |
|
|
PRVL
1649
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $9.61M | ﹤0.01% |
788,600
-83,400
| -10% | -$1.33M |
|
1650
Invesco S&P International Developed Low Volatility ETF
IDLV
$344M
| $9.6M | ﹤0.01% |
365,160
+362,799
| +15,366% | +$11.5M |
|
Similar funds
Fidelity Investments's Q1 2020 Portfolio in Review
As of Q1 2020, Fidelity Investments held 4,600 positions worth $722B, down 20% from $906B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Fidelity Investments's Q1 2020 filing shows 372 new, 1,381 increased, 1,824 reduced and 431 closed positions. Its largest new stake was 1Life Healthcare: 9,509,562 shares worth $164M. The largest sale was Amgen, an estimated $1.49B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Fidelity Investments's largest Q1 2020 buy was 1Life Healthcare: 9,509,562 shares worth $164M.
- Fidelity Investments added most to Regeneron Pharmaceuticals in Q1 2020, an estimated $2.16B increase.
- Fidelity Investments's biggest Q1 2020 reduction was Amgen, cutting an estimated $1.49B.
- Fidelity Investments fully exited Taubman Centers Inc. in Q1 2020, selling an estimated $106M.
- Fidelity Investments's ten largest holdings make up 27% of its $722B portfolio in Q1 2020.
- Fidelity Investments opened 372 new positions and closed 431 in Q1 2020.
- Fidelity Investments's portfolio value fell 20% quarter-over-quarter to $722B.
Based on Fidelity Investments's 13F filing for Q1 2020, filed 14 May 2020.